Log in
0 followers
Step Pharma is developing a novel class of oral nucleotide synthesis inhibitors specifically targeting cytidine triphosphate synthase 1 (CTPS1) to induce selective modulation of T and B cell populations.
Industries
Headquarters
Employees
Links
Andrew Parker
9 members
6 members
3 members
2 members
Seagate
38 followers
PickStar
26 followers
Rad Frames
3 followers
Basis
59 followers
Australian Medical Students' Association
196 followers
Discover companies